Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.36
Delayed Data
As of May 25
 +0.01 / +0.43%
Today’s Change
1.13
Today|||52-Week Range
4.37
-28.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues55.8K46.9K74.7K41.5K
 
 
 
 
 
Cost of Goods Sold34.2K30.7K57.9K50.7K
 
 
 
 
 
Depreciation And Amortization1.4K1.4K1.4K711.00
 
 
 
 
 
 
Operating ExpensesGross Income20.2K14.7K15.4K-9.9K
 
 
 
 
 
General Expenses5.3M10.0M4.0M3.3M
 
 
 
 
 
Research And Development482.7K5.2M2.4M1.7M
 
 
 
 
 
Total Operating Expenses5.3M10.0M4.1M3.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.3M-10.0M-4.0M-3.3M
 
 
 
 
 
Interest Expense On Debt56.9K29.7K84.5K58.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-10.0M-4.1M-3.3M
 
 
 
 
 
Net Income-5.3M-10.0M-4.1M-3.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.2M39.1M43.0M44.0M
 
 
 
 
 
Shares To Calculate EPS Diluted37.2M39.1M43.0M46.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.26-$0.10-$0.08
 
 
 
 
 
EPS Diluted-$0.14-$0.26-$0.10-$0.08